Dr. Buse received his medical degree and PhD from Duke University in Durham, North Carolina before training in internal medicine and endocrinology at the University of Chicago. He is currently a professor at the University of North Carolina School of Medicine in Chapel Hill, North Carolina where he serves as the Chief of the Division of Endocrinology.

        Dr. Buse has a diabetes practice located at UNC as well as at the Salem Center in Winston-Salem, North Carolina. His research interests focus on developing prevention and treatment strategies for type 1 diabetes, type 2 diabetes and their complications. He has authored more than 100 publications and is involved in numerous multicenter clinical trials, most prominently the National Heart Lung and Blood Institute’s ACCORD (Action to Control Cardiovascular Risk in Diabetes) study for which he serves as Study Vice-Chair and the National Institute for Diabetes Digestive and Kidney Disease’s STOPP-T2D (Studies to Treat Or Prevent Pediatric Type 2 Diabetes) study. He serves on the Data Safety Monitoring Board or Steering Committee for NIH and international studies such as NAVIGATOR, ORIGIN, IRIS, FREEDOM and NASH CRN. Dr. Buse is active in a number of national teaching efforts focusing on graduate medical education as well as CME including programs.

        Dr Buse is also President for Medicine and Science at the American Diabetes Association and a board member of the Carolinas Affiliate of the American Association of Clinical Endocrinologists. He has received numerous awards and honors, including citation in Best Doctors in America since 2001.

        He is the extremely proud father of two teenage daughters, Katherine and Caroline, and the husband of a remarkable woman, Laura Raftery, currently a fellow in Oncology.